Ingex Lab Private Limited - Due diligence report

A 360° intelligence report on Ingex Botanicals: trust score, financial health, credit view, compliance, directors, growth and distress signa…

2017-09-01 Bangalore, Karnataka Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Ingex Botanicals — 360° Intelligence Report

Generated from MCA filings & public records
64/100
Trust Score
Moderate

Ingex Botanicals is assessed as Moderate with a Trust Score of 64/100. Ingex Botanicals is an active private limited indian non-government company incorporated in 2017, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 22 Nov 2026 from the latest processed filings. Ingex Lab Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
64/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
50/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 0 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 5 open ( 48.0 cr ) · 2 satisfied ( 12.5 cr ).

Banking relationships (from registered charges)
LenderChargesAmount
Others5 48.0 cr
State Bank Of India2 48.0 cr
Compliance Score: 50/100 Moderate
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2024 - filings overdue.
  • Litigation present in 1 court forum(s).
  • 2 auditor resignation(s) filed - latest: DELOITTE HASKINS & SELLS LLP on 2021-03-19.
  • Delayed payments to MSME suppliers disclosed (23 disclosure(s)).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
SUDHEER KARAT 01234567 Director 01/04/2018 6 yrs Approved
SAUDMUHAMED 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • SUDHEER KARAT has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
4
Group entities
4
Capital events
0 allotment(s) · 3 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Ingex Botanicals Private Limited Subsidiary Company 74.00%
Ingex Foods Private Limited Subsidiary Company 74.00%
Ingex Germany, Gmbh Subsidiary Company 74.00%
Nutrinorm Wellness Private Limited Subsidiary Company 74.00%
Nature Sunshine Fzc Subsidiary Company 74.00%
Aalps Nutra Tech Private Limited Subsidiary Company 74.00%
Zinple Info Solutions Private Limited Subsidiary Company 74.00%

Key managerial personnel: SAUDMUHAMED (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 55
Growth signals & trust indicators
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
Operating for 9 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Outside liabilities up 61% in a year.
Statutory filings appear overdue.
Compliance score is weak (50/100).
5 open charge(s) registered - assets are encumbered.
2 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence56/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment75/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 5 open charge(s) already registered.
  • Compliance gaps should be priced into terms.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
24 Mar 2025
Charge created
Others - 15.60 cr
09 Dec 2024
Charge satisfied
State Bank Of India
30 Sep 2024
Last AGM held
Annual general meeting
28 Jun 2024
Charge created
Others - 2.30 cr
Charge created
Others - 4.93 cr
31 Mar 2024
Latest balance sheet
Filed with ROC
26 Dec 2023
Charge created
Others - 30.00 cr
02 Aug 2022
Charge satisfied
Others
04 Jul 2022
Charge created
State Bank Of India - 5.55 cr
31 Jan 2022
Charge created
State Bank Of India - 21.39 cr
26 Mar 2021
Director ceased
SUDHEER KARAT
17 Dec 2020
Director appointed
SUDHEER KARAT (Director)
Director ceased
BAIDYANATH MISHRA
31 Mar 2020
Share transfer (FY 2020)
4999.00000000 shares to SAUD MOHAMED
Share transfer (FY 2020)
1.00000000 shares to SUJAN GANAPATHY
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
2 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 4 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
3 overseas direct investment(s) (ODI) on record - international footprint.
Approximately 17 employees on EPFO payroll records.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Bhikhaaram U15433WB2005PTC102390 Kolkata, West Bengal, India
Bharat Glucose Private Limited U15231HR2005PTC035787 Karnal, Haryana, India
Jagdish Foods Pvt. Ltd. U15499GJ1986PTC008670 Vadodara, Gujarat, India
Gyanlaxmi Sugar Private Limited U15432UP2020PTC132936 Bareilly, Uttar Pradesh, India
Gayatri Dairy Products Private Limited U15200GJ1985PTC007965 Ahmedabad, Gujarat, India
Amarnath Foods U15499RJ2002PTC057468 Jaipur, Rajasthan, India
Fishfa Agri World Limited U01132GJ2013PLC074858 Rajkot, Gujarat, India
Kishlayfoods U15311AS2001PTC006660 Guwahati, Assam, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Ingex Botanicals before audits and certifications: compliance score 50/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Ingex Botanicals: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Ingex Botanicals - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 64/100, distress signals and MSME payment-delay disclosures - know whether Ingex Botanicals pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Ingex Botanicals - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Ingex Botanicals an active company?

Ingex Botanicals has MCA status “Active” with a compliance score of 50/100 (Moderate).

Is Ingex Botanicals financially healthy?

Ingex Botanicals has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Ingex Botanicals?

Its overall Trust Score is 64/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Ingex Botanicals?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Ingex Botanicals have loans or charges against its assets?

5 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.

Is Ingex Botanicals up to date with its ROC filings?

Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 50/100 (Moderate).

Is it risky to lend to Ingex Botanicals?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.